|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenues | |||||
| Total product sales, net | |||||
| Total revenues from collaborations | |||||
| Government contracts | |||||
| Total revenues | |||||
| Costs and expenses: | |||||
| Cost of product sales | |||||
| Research and development | |||||
| Selling, general and administrative | |||||
| Total costs and expenses | |||||
| Income (loss) from operations | |||||
| Interest income | |||||
| Interest expense | |||||
| Income (loss) before income taxes | |||||
| (Benefit from) provision for income taxes | |||||
| Net income (loss) | |||||
| Net income (loss) per share | |||||
| Basic (in dollars per share) | |||||
| Diluted (in dollars per share) | |||||
| Weighted average shares used in computing net income (loss) per share | |||||
| Basic (in shares) | |||||
| Diluted (in shares) | |||||
Loading...